4//SEC Filing
Coen Stacy Ann 4
Accession 0001415889-24-002873
CIK 0000855654other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 9:47 PM ET
Size
8.9 KB
Accession
0001415889-24-002873
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Coen Stacy Ann
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2024-02-02+14,350→ 77,857 total - Sale
Common Stock
2024-02-05$29.30/sh−4,583$134,282→ 73,274 total - Exercise/Conversion
Restricted Stock Unit
2024-02-02−14,350→ 28,700 totalExercise: $0.00→ Common Stock (14,350 underlying)
Footnotes (3)
- [F1]Effected pursuant to a trading plan adopted on June 15, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F3]The RSUs were awarded on 2/3/2023 and vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001814150
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 9:47 PM ET
- Size
- 8.9 KB